Evaluation of the Goldcrest Patch Performance
Active, not recruiting
- Conditions
- Fetal Monitoring
- Interventions
- Device: Goldcrest Patch and Three Patch CouponsDevice: Goldcrest Patch and Novii Patch
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 30
- Registration Number
- NCT06355453
- Locations
- 🇺🇸
GE HealthCare Research Park, Wauwatosa, Wisconsin, United States
Wireless Disposable SpO2 Sensor Hypoxia Testing
Not Applicable
Completed
- Conditions
- SpO2Peripheral Oxygen Saturation Measurement
- Interventions
- Device: SpO2 Sensor Testing
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 32
- Registration Number
- NCT06211530
- Locations
- 🇺🇸
Element Materials Technology, Louisville, Colorado, United States
Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque
Not yet recruiting
- Conditions
- Coronary Artery DiseaseChronic Coronary SyndromeAcute Coronary SyndromeStable Angina
- Interventions
- Other: Deep Learning-based Vulnerable Plaque Detection and Assessment Tool
- First Posted Date
- 2024-01-02
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 200
- Registration Number
- NCT06186336
- Locations
- 🇮🇹
Ospedale Di Voghera, Azienda Socio-Sanitaria Territoriale di Pavia, Pavia, Lombardy, Italy
Clinical Data Collection and Evaluation of ECG-Less Cardiac CT
Completed
- Conditions
- Cardiac CT
- Interventions
- Device: ECG-Less Cardiac CT using SmartPhase
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 56
- Registration Number
- NCT05949138
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸University of Washington, Seattle, Washington, United States
Clinical Data Collection in Breast Tomosynthesis (COBRIS)
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Device: Breast Tomosynthesis
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 150
- Registration Number
- NCT05914168
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, France
Clinical Feasibility and Evaluation of Silicon Photon Counting CT
Recruiting
- Conditions
- CT Photon-Counting
- Interventions
- Device: CT Photon-Counting
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 100
- Registration Number
- NCT05838482
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
Clinical Data Collection On Advanced CT System
Recruiting
- Conditions
- CT Photon Counting
- Interventions
- Device: Investigational Edge-on Silicon Photon Counting CT device
- First Posted Date
- 2023-04-28
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 120
- Registration Number
- NCT05835284
- Locations
- 🇸🇪
Karolinska University Hospital, Solna, Sweden
Data Collection for Validation of an NIBP Algorithm in Pregnant Women
Not Applicable
Recruiting
- Conditions
- Blood Pressure
- Interventions
- Device: Collecting blood pressure measurements with noninvasive blood pressure device
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 170
- Registration Number
- NCT05789849
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
Phase 2
Terminated
- Conditions
- Parkinson DiseaseMovement Disorders
- Interventions
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 15
- Registration Number
- NCT05636852
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇺🇸University of Mississippi Medical Center (UMMC), Jackson, Mississippi, United States
Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer
Phase 1
Not yet recruiting
- Conditions
- Breast Cancer
- Interventions
- Drug: GEH121224 (18F) InjectionDiagnostic Test: Dynamic and Static - PET/CT ScanDiagnostic Test: Static - PET/CT Scan
- First Posted Date
- 2022-12-02
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 12
- Registration Number
- NCT05634954
- Locations
- 🇺🇸
The University of Texas MD Anderson Cancer Centre, Houston, Texas, United States